Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands		Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock Issued	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings (Deficit)	Retained Earnings (Deficit) Cumulative Effect, Period of Adoption, Adjustment	Treasury stock
Beginning balance (in shares) at Dec. 31, 2019	[1]			415,700,000
Beginning balance at Dec. 31, 2019	[1]	$ 1,985,218		$ 42	$ 1,347,613		$ 637,563		$ 0
Beginning balance (in shares) at Dec. 31, 2019	[1]								0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Class B Unit expense		405,843			405,843
2020 Omnibus Incentive Plan (Note 15) (in shares)				31,250					13,087
2020 Omnibus Incentive Plan (Note 15)		(94)			(211)				$ (117)
Effect of the Mergers (Note 4) (in shares)				128,806,148
Effect of the Mergers (Note 4)		(548,623)		$ 13	(548,636)
Private Placement Warrants and unvested founder shares (Note 10) (in shares)				(12,404,080)
Private Placement Warrants and Unvested Founder Shares (Note 10)		(142,019)		$ (2)	(142,017)
PIPE Investment, net of costs (Note 4) (in shares)				132,050,000
PIPE Investment, net of costs (Note 4)		1,467,409		$ 13	1,467,396
Treasury stock purchases/ repurchase of common stock (in shares)									(9,094,876)
Treasury stock purchases / repurchase of common stock		(89,493)							$ (89,493)
Net (loss) income		(520,564)					(520,564)
Ending balance (in shares) at Dec. 31, 2020				664,183,318
Ending balance at Dec. 31, 2020		2,557,865	$ (227,841)	$ 66	2,530,410	$ (233,874)	116,999	$ 6,033	$ (89,610)
Ending balance (in shares) at Dec. 31, 2020									(9,107,963)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
2020 Omnibus Incentive Plan (Note 15) (in shares)				1,272,862
2020 Omnibus Incentive Plan (Note 15)		(16,355)		$ (1)	(16,354)
Tax withholding related to vesting of equity awards (in shares)									(345,733)
Tax withholding related to vesting of equity awards		(3,789)			(1,230)				$ (2,559)
Treasury stock purchases/ repurchase of common stock (in shares)									(17,663,710)
Treasury stock purchases / repurchase of common stock		(100,000)							$ (100,000)
Net (loss) income		$ 102,080					102,080
Ending balance (in shares) at Dec. 31, 2021		638,338,774		665,456,180
Ending balance at Dec. 31, 2021		$ 2,344,670		$ 67	2,311,660	$ (233,900)	225,112		$ (192,169)
Ending balance (in shares) at Dec. 31, 2021									(27,117,406)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
2020 Omnibus Incentive Plan (Note 15) (in shares)				834,164
2020 Omnibus Incentive Plan (Note 15)		(16,739)			(16,739)
Tax withholding related to vesting of equity awards		(2,463)			(2,463)
Reclassification of Private Placement Warrants (Note 10)		4,508			4,508
Net (loss) income		$ (572,912)					(572,912)
Ending balance (in shares) at Dec. 31, 2022		639,172,938		666,290,344
Ending balance at Dec. 31, 2022		$ 1,790,542		$ 67	$ 2,330,444		$ (347,800)		$ (192,169)
Ending balance (in shares) at Dec. 31, 2022									(27,117,406)

[1] The shares of the Company's common stock, prior to the Transactions, have been retroactively restated as shares reflecting the exchange ratio established in the Transactions.